Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$93,060,749
+$31,914,741 QoQ
Shares Held
369,817
+31.5% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#264
of 4,152 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UniSuper Management Pty Ltd holds $763,193,679 across 9 Drug Manufacturers - General names. ABBV ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
193,999 | $232,688,239 | |
| 2 | JNJ |
Johnson & Johnson
|
655,534 | $166,485,969 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,188,632 | $152,739,212 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
369,817 | $93,060,749 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
351,688 | $44,432,261 | |
| 6 | AMGN |
Amgen Inc
|
116,483 | $42,180,823 | |
| 7 | PFE |
Pfizer Inc
|
624,923 | $15,048,145 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
224,641 | $12,943,814 |
All Filings in ABBV
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,060,749 | 369,817 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $61,146,008 | 281,144 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $57,854,353 | 253,203 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $58,207,766 | 251,394 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $42,664,200 | 229,847 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $48,736,028 | 232,608 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $17,669,777 | 99,436 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $16,538,160 | 83,746 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,756,418 | 80,203 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $5,450,253 | 29,930 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $24,422,652 | 157,596 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $25,918,552 | 173,880 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||